Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Fibrocystic breast disease
ADR ID BADD_A01654
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.14      Breast neoplasms benign (incl nipple)
16.14.01      Breast and nipple neoplasms benign
16.14.01.003      Fibrocystic breast disease
21      Reproductive system and breast disorders
21.05      Breast disorders
21.05.01      Benign and malignant breast neoplasms
21.05.01.002      Fibrocystic breast disease
Description A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency. | A benign lesion of the BREAST, characterized by a proliferation of disorganized small glands lined by EPITHELIAL CELLS without apparent myoepithelial cells. These glands usually have enlarged lumens, and lie in adipose or fibrous tissue. [MeSH]
MedDRA Code 10016621
MeSH ID D005348; D005348; D005348
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adenosis sclerosing | Breast cystic fibrosis | Breast fibrocystic | Breast fibrocystic change | Breast fibrocystic disorder | Breast mass fibrocystic | Cystic disease of breast (benign) | Diffuse cystic mastopathy | Disease cystic breast | Disease fibrocystic breast | Fibrocystic breast | Fibrocystic breast disease | Fibrocystic disease of breast | Mass breast fibrocystic | Fibrocystic disease | Fibrous mastopathy | Reclus disease | Fibrocystic Breast Disease | Breast Disease, Fibrocystic | Disease, Fibrocystic Breast | Mammary Dysplasia | Dysplasia, Mammary | Fibrocystic Disease of Breast | Breast Fibrocystic Disease | Fibrocystic Mastopathy | Mastopathy, Fibrocystic | Breast Dysplasia | Dysplasia, Breast | Fibrocystic Changes of Breast | Breast Fibrocystic Change | Breast Fibrocystic Changes | Microglandular Adenosis | Adenoses, Microglandular | Adenosis, Microglandular | Microglandular Adenoses | Adenosis of Breast | Breast Adenosis | Chronic Cystic Mastitis | Cystic Mastitis, Chronic | Cystic Breast Disease | Breast Disease, Cystic | Disease, Cystic Breast | Cystic Disease of Breast | Breast Cystic Disease | Breast Cystic Diseases
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.002425%
BADD_D00182Atorvastatin calcium--
BADD_D00497Clomiphene--
BADD_D00498Clomiphene citrate--
BADD_D00528Conjugated estrogens--
BADD_D00706Donepezil--
BADD_D00707Donepezil hydrochloride--
BADD_D00793Equilin sulfate--
BADD_D00820Esterified estrogens--
BADD_D00821Estradiol--
BADD_D00822Estradiol acetate--
BADD_D00823Estradiol cypionate--
BADD_D00824Estradiol hemihydrate--
BADD_D00825Estradiol valerate--
BADD_D00831Estrogens--
BADD_D00832Estrogens conjugated synthetic a--
BADD_D00833Estrogens conjugated synthetic b--
BADD_D00834Estrone--
BADD_D00835Estrone sulfate--
BADD_D00836Estropipate--
BADD_D00932Fluoxetine--
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01281Levonorgestrel0.008338%
BADD_D01365Medroxyprogesterone--
BADD_D01366Medroxyprogesterone acetate0.000511%
BADD_D01586Norethindrone acetate--
BADD_D01590Nuvaring--
BADD_D01679Paroxetine--
BADD_D01680Paroxetine hydrochloride--
The 1th Page    1 2    Next   Last    Total 2 Pages